Comparison of the studied parameters in the study and control groups , showed a more rapid decrease in the symptoms and signs of intoxication ( leukocytosis , LII , body temperature ) , relief of enteric disease , recovery of protein-synthetic function of the liver , a decrease of cytolytic and mesenchymal-inflammatory syndrome in the study group , especially in the subgroup in which therapy was included remaxol .